Literature DB >> 25753847

Longitudinal brain volumetric changes and their predictive effects on cognition among cognitively asymptomatic patients with Parkinson's disease.

Ming-Ching Wen1, Aloysius Ng1, Russell Jude Chander1, Wing Lok Au2, Louis C S Tan2, Nagaendran Kandiah3.   

Abstract

INTRODUCTION: Existing literature on brain volumetric alterations in patients with Parkinson's disease (PD) have mainly focused on gray matter (GM) and are largely cross-sectional. Little is known about white matter (WM) volumetric features and their impact on cognitive symptoms in PD. Therefore, the present study aims to examine both GM and WM volumes of cognitively asymptomatic PD patients with a longitudinal design.
METHODS: A total of 42 cognitively asymptomatic patients with early stage PD were recruited and followed up for 1.5 years. At follow-up, 12 patients progressed to mild cognitive impairment (MCI) and were classified as "converters" while the remaining 30 patients remained cognitively asymptomatic and were classified as "non-converters". All patients underwent clinical and neuropsychological assessments as well as MRI scans at baseline and at follow-up.
RESULTS: At baseline, non-converters and converters had comparable cognitive scores. At follow-up, converters showed more deficits in frontal-related cognitive function than non-converters. Volumetric analyses revealed that converters had more longitudinal reduction in WM, but not GM, volume compared to non-converters. The decreased volumes among converters were mainly localized in the frontal areas. Moreover, baseline global WM volume significantly predicted conversion to PD-MCI, while baseline GM and WM volumes of the frontal and parietal regions were associated with frontal cognitive changes across time.
CONCLUSION: PD patients who develop MCI demonstrate longitudinal reduction in WM volume, especially in the frontal areas. While both regional GM and WM volumes associate with frontal cognitive decline, baseline global WM volume may be a neuroimaging marker of conversion to PD-MCI.
Copyright © 2015 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Frontal-related dysfunction; Longitudinal study; Mild cognitive impairment; White matter

Mesh:

Year:  2015        PMID: 25753847     DOI: 10.1016/j.parkreldis.2015.02.014

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  7 in total

1.  Longitudinal white matter microstructural change in Parkinson's disease.

Authors:  Vincent Pozorski; Jennifer M Oh; Nagesh Adluru; Andrew P Merluzzi; Frances Theisen; Ozioma Okonkwo; Amy Barzgari; Stephanie Krislov; Jitka Sojkova; Barbara B Bendlin; Sterling C Johnson; Andrew L Alexander; Catherine L Gallagher
Journal:  Hum Brain Mapp       Date:  2018-06-27       Impact factor: 5.038

2.  Frontal atrophy as a marker for dementia conversion in Parkinson's disease with mild cognitive impairment.

Authors:  Seok Jong Chung; Han Soo Yoo; Yang Hyun Lee; Hye Sun Lee; Byoung Seok Ye; Young H Sohn; Hunki Kwon; Phil Hyu Lee
Journal:  Hum Brain Mapp       Date:  2019-05-14       Impact factor: 5.038

3.  Tracking Parkinson's Disease over One Year with Multimodal Magnetic Resonance Imaging in a Group of Older Patients with Moderate Disease.

Authors:  Tracy R Melzer; Daniel J Myall; Michael R MacAskill; Toni L Pitcher; Leslie Livingston; Richard Watts; Ross J Keenan; John C Dalrymple-Alford; Tim J Anderson
Journal:  PLoS One       Date:  2015-12-29       Impact factor: 3.240

Review 4.  Gray Matter Changes in Parkinson's and Alzheimer's Disease and Relation to Cognition.

Authors:  Lenka Krajcovicova; Patricia Klobusiakova; Irena Rektorova
Journal:  Curr Neurol Neurosci Rep       Date:  2019-11-13       Impact factor: 5.081

Review 5.  Magnetic Resonance Imaging Markers for Cognitive Impairment in Parkinson's Disease: Current View.

Authors:  Yanbing Hou; Huifang Shang
Journal:  Front Aging Neurosci       Date:  2022-01-25       Impact factor: 5.750

Review 6.  Mild cognitive impairment in patients with Parkinson's disease: An updated mini-review and future outlook.

Authors:  Rwei-Ling Yu; Ruey-Meei Wu
Journal:  Front Aging Neurosci       Date:  2022-09-06       Impact factor: 5.702

Review 7.  Mild cognitive impairment in Parkinson's disease: a distinct clinical entity?

Authors:  Ming-Ching Wen; Ling Ling Chan; Louis C S Tan; Eng King Tan
Journal:  Transl Neurodegener       Date:  2017-09-13       Impact factor: 8.014

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.